Post-earnings recap
Reported
Thu, Aug 8, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a strong earnings per share, exceeding expectations by 15.47%. This positive EPS surprise contributed to a 1.93% increase in the stock price, indicating investor confidence despite the lack of revenue data and management commentary.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.62 | N/A | +15.47% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.